Solid Organ Transplant Market Research Report, By Type Of Organ (Heart, Kidney, Others), By Products (Organ Preservation Solutions, Transplant Diagnostics, Tissue Products), By Type Of Transplant (Autograft, Allograft And Others), By Treatment (Analgesic, Immunosuppressant And Other), By End Users (Hospitals, Transplant Centers And Other) - Global Forecast Till 2023
The Global Solid Organ Transplant Market is predicted to grow at a 9.8% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Organ transplantation, simply put, is a medical procedure where an organ gets removed from a human body and placed in the recipient’s body for replacing a missing or damaged organ. Organs which can be successfully transplanted include thymus, intestine, pancreas, lungs, liver, kidneys, and the heart. Often times, double transplants are performed, such as heart/lung or kidney/pancreas.
There are several diseases that can cause organ failures such as cirrhosis, cystic fibrosis, hepatitis, diabetes, and heart disease. Birth defects and injury can also result in organ failure. Resting on the organ required, organs will be matched using various characteristics, which includes the organ size needed and the blood type.
Various factors are propelling the organ transplantation market growth. Some of these factors, according to the Market Research Future (MRFR) report, include changing lifestyle, rising aging population, growing prevalence of various chronic diseases, and technological developments.
On the contrary, rising incidences of organ failure coupled with high treatment cost are factors that may restrict the organ transplantation market growth over the forecast period.
Organ Transplantation Market Key Players
Key players profiled in the organ transplantation market report include GlaxoSmithKline Plc. (UK), Veloxis Pharmaceuticals A/S (Denmark), Pfizer, Inc. (US), Sanofi (France), Accord Healthcare GmbH (Spain), TransMedic, Inc. (US), Transplant Biomedical (UK), Bio Med Pvt. Ltd. (US), OrganOX Limited (UK), Preservation Solutions, Inc. (US), Astellas Pharma, Inc (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), Transonic (US), Terumo Medical Corporation (US), and Novartis International AG (Switzerland). Key players are incorporating several strategies to create a niche in the market such as partnerships, collaborations, mergers and acquisitions, research and development, innovations, and more.
Organ Transplantation Market Segmentation
The MRFR report provides a complete segmental analysis of the organ transplantation market on the basis of end users, treatment, type of transplant, products, and type of organ.
Based on type of organ, the organ transplantation market is segmented into lungs, liver, kidney, heart, and others.
Based on products, the organ transplantation market is segmented into tissue products, transplant diagnostics, organ preservation solutions, and others.
Based on type of transplant, the organ transplantation market is segmented into xenograft and xenotransplantation, allograft and allotransplantation, autograft, and others.
Based on treatment, the organ transplantation market is segmented into steroids, antiproliferative agents, mTOR inhibitor, calcineurin inhibitors, and others. The calcineurin inhibitors segment is further segmented into cyclosporine and tacrolimus, and the mTOR inhibitor segment is further segmented into everolimus and sirolimus.
Based on end users, the organ transplantation market is segmented into transplant centers, hospitals, and others.
Organ Transplantation Market Regional Analysis
By region, the organ transplantation market report covers the latest trends and growth opportunities across the Europe, the Asia Pacific (APAC), North America, and the Rest of the World (RoW). Of these, North America will spearhead the market over the forecast period. This is owing to rising incidences of organ failure, strong healthcare expenditure, noteworthy development in the medical industry, and well-established healthcare sectors.
The organ transplantation market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the growing healthcare infrastructure and growing research on stem cells for developing organs and invitro tissues.
The organ transplantation market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the presence of nations that are steadily developing and a huge population pool that is afflicted with various chronic diseases. Besides, several NGOs and governments are adopting numerous initiatives which are encouraging people in donating organs, thus saving lives.
The global organ transplantation market in the Middle East and Africa is predicted to have a lucrative growth over the forecast period. This is due to the use of technology and media for increasing awareness, government legislations, and ongoing investments in the current models of organ donation.